# Naltrexone Neuroimaging

> **NCT04935931** · EARLY_PHASE1 · COMPLETED · sponsor: **Children's Mercy Hospital Kansas City** · enrollment: 13 (actual)

## Conditions studied

- Eating Disorders
- Binge Eating
- Purging (Eating Disorders)

## Interventions

- **DRUG:** Naltrexone

## Key facts

- **NCT ID:** NCT04935931
- **Lead sponsor:** Children's Mercy Hospital Kansas City
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-16
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-06-30
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-10-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04935931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04935931, "Naltrexone Neuroimaging". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04935931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*